Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

I am new to this message board, but

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
SloDan Member Profile
 
Followed By 0
Posts 4
Boards Moderated 0
Alias Born 10/02/19
160x600 placeholder
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock GlobeNewswire Inc. - 2/18/2021 4:01:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/17/2021 5:10:29 PM
Bio-Path slips 8% on capital raise Seeking Alpha - 2/16/2021 7:41:11 AM
Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock GlobeNewswire Inc. - 2/16/2021 7:15:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/16/2021 7:02:13 AM
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 2/13/2021 7:00:00 AM
Bio-Path stock soars on U.S. patent grant Seeking Alpha - 2/10/2021 10:48:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/10/2021 9:18:21 AM
APHA, TLRY, SNDL and OGI among premarket gainers Seeking Alpha - 2/10/2021 8:23:26 AM
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology GlobeNewswire Inc. - 2/10/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2020 4:18:59 PM
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002 GlobeNewswire Inc. - 11/19/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 7:12:10 AM
Bio-Path Holdings Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/13/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:12:44 PM
Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020 GlobeNewswire Inc. - 11/6/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/5/2020 4:25:40 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/5/2020 4:20:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:31:22 PM
Bio-Path Receives Notice of Allowance for Strategic Patent for Prexigebersen in Combination with Front Line Cytidine Analogue... GlobeNewswire Inc. - 10/22/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2020 4:17:35 PM
Bio-Path Holdings to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM
Bio-Path Holdings Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/14/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2020 4:31:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 4:12:37 PM
SloDan   Thursday, 10/03/19 03:29:57 PM
Re: None
Post # of 6320 
I am new to this message board, but I've been a share holder of BPTH for just under 4 yrs. now. In following this 'Message Board' it has helped me understand the history of this company. I have felt the disappointments & losses of this stock like most. I read the following article on Yahoo/Finance about BPTH's CEO a few days ago. IMO this company has been the personal PIGGY BANK for Peter Nielsen. One can only HOPE that this Science out performs the actions and mismanagement of the CEO.
https://finance.yahoo.com/quote/BPTH/history?p=BPTH

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences